Annelies Jorritsma‐Smit

89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Frederike Bensch, Elly L. van der Veen, Marjolijn N. Lub–de Hooge et al. · Nature Medicine · 2018 · 702 citations · Full text

Oncologic Imaging, Pd-l1 Blockade, Medicine +11

Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts, Maximillian Koch, Johannes S. de Jong et al. · Clinical Cancer Research · 2016 · 267 citations · Full text

Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up

Joost H. van den Berg, Bianca Heemskerk, Nienke van Rooij et al. · Journal for ImmunoTherapy of Cancer · 2020 · 184 citations · Full text

Molecular fluorescence-guided surgery of peritoneal carcinomatosis of colorectal origin: a single-centre feasibility study

Niels J. Harlaar, Marjory Koller, Steven J. de Jongh et al. · ˜The œLancet. Gastroenterology & hepatology · 2016 · 177 citations · Full text

Surgical Oncology, Colorectal Surgery, Peritoneal Carcinomatosis +12

Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers

Marjory Koller, Siqi Qiu, Matthijs D. Linssen et al. · Nature Communications · 2018 · 130 citations · Full text